Follitropin alpha (r-FSH)
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Ovulation Induction
Conditions
Ovulation Induction
Trial Timeline
Mar 1, 2004 → Jun 1, 2005
NCT ID
NCT01111084About Follitropin alpha (r-FSH)
Follitropin alpha (r-FSH) is a pre-clinical stage product being developed by Merck for Ovulation Induction. The current trial status is completed. This product is registered under clinical trial identifier NCT01111084. Target conditions include Ovulation Induction.
What happened to similar drugs?
3 of 5 similar drugs in Ovulation Induction were approved
Approved (3) Terminated (2) Active (2)
🔄SHR7280；Ganirelix Acetate Injection simulant + SHR7280 simulant； Ganirelix Acetate InjectionJiangsu Hengrui MedicinePhase 3
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01111084 | Pre-clinical | Completed |
Competing Products
13 competing products in Ovulation Induction